Skip to main content
. 2024 Dec 13;103(50):e40946. doi: 10.1097/MD.0000000000040946

Table 2.

Correlation analysis between BRT-based biomarkers and BMD in chronic HF patients.

BMD L2–L4 BMD FN
r P value r P value
Hemoglobin (g/L) 0.143 <.0001 0.174 <.0001
RBC (1012/L) 0.122 <.0001 0.105 .001
WBC (109/L) ‐0.022 .476 ‐0.072 .020
Neutrophil (109/L) ‐0.040 .201 ‐0.077 .013
Monocyte (109/L) 0.044 .157 ‐0.063 .041
Lymphocyte (109/L) ‐0.031 .320 0.005 .879
Eosinophil (109/L) 0.059 .055 0.041 .180
Basophil (109/L) ‐0.014 .641 0.015 .632
Platelets (109/L) ‐0.057 .067 ‐0.069 .025
NLR 0.036 .244 0.057 .063
PLR ‐0.031 .309 ‐0.056 .071
LMR ‐0.056 .069 0.022 .477
SII ‐0.013 .679 ‐0.050 .108

BMD = bone mineral density, BRT = blood routine test, FN = femoral neck, HF = heart failure, LMR = lymphocyte-to-monocyte ratio, L2–L4 = lumbar vertebrae 2 to 4, NLR = neutrophil-to-lymphocyte ratio, PLR = platelet-to-lymphocyte ratio, RBC = red blood cells, SII = systemic immune-inflammation index, WBC = white blood cells.